Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares OutstandingShares Outstanding
Ratios

Pliant Therapeutics (PLRX) Receivables - Net (2019 - 2023)

Pliant Therapeutics has reported Receivables - Net over the past 5 years, most recently at $1.6 million for Q2 2023.

  • Quarterly Receivables - Net fell 68.33% to $1.6 million in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Jun 2023, down 68.33% year-over-year, with the annual reading at $2.0 million for FY2022, 0.75% down from the prior year.
  • Receivables - Net was $1.6 million for Q2 2023 at Pliant Therapeutics, down from $3.3 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $9.3 million in Q4 2020 and troughed at $1.2 million in Q1 2022.
  • The 5-year median for Receivables - Net is $2.1 million (2021), against an average of $3.5 million.
  • Year-over-year, Receivables - Net crashed 78.47% in 2021 and then surged 172.62% in 2022.
  • A 5-year view of Receivables - Net shows it stood at $7.1 million in 2019, then skyrocketed by 31.58% to $9.3 million in 2020, then crashed by 78.47% to $2.0 million in 2021, then decreased by 0.75% to $2.0 million in 2022, then dropped by 20.32% to $1.6 million in 2023.
  • Per Business Quant, the three most recent readings for PLRX's Receivables - Net are $1.6 million (Q2 2023), $3.3 million (Q1 2023), and $2.0 million (Q4 2022).